Jefferies analyst Stephen Barker downgraded PeptiDream to Hold from Buy with a price target of 1,900 yen, down from 2,200 yen. The analyst has become more optimistic about the company’s radiopharma revenues, but less optimistic about margins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PPTDF: